Monday 26 January 2009

Oxicobal




Oxicobal may be available in the countries listed below.


Ingredient matches for Oxicobal



Mecobalamin

Mecobalamin is reported as an ingredient of Oxicobal in the following countries:


  • Indonesia

International Drug Name Search

Thursday 22 January 2009

Oxybuprocaine Hydrochloride




Oxybuprocaine Hydrochloride may be available in the countries listed below.


Ingredient matches for Oxybuprocaine Hydrochloride



Oxybuprocaine

Oxybuprocaine Hydrochloride (BANM, USAN) is also known as Oxybuprocaine (Rec.INN)

International Drug Name Search

Glossary

BANMBritish Approved Name (Modified)
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday 21 January 2009

Betaday




Betaday may be available in the countries listed below.


Ingredient matches for Betaday



Bambuterol

Bambuterol is reported as an ingredient of Betaday in the following countries:


  • Myanmar

Bambuterol hydrochloride (a derivative of Bambuterol) is reported as an ingredient of Betaday in the following countries:


  • Sri Lanka

International Drug Name Search

Monday 19 January 2009

Di-Flea




Di-Flea may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Di-Flea



Cypermethrin

Cypermethrin is reported as an ingredient of Di-Flea in the following countries:


  • Australia

Piperonyl Butoxide

Piperonyl Butoxide is reported as an ingredient of Di-Flea in the following countries:


  • Australia

Pyrethrin I

Pyrethrin I is reported as an ingredient of Di-Flea in the following countries:


  • Australia

International Drug Name Search

Saturday 17 January 2009

Onco-Carbide




Onco-Carbide may be available in the countries listed below.


Ingredient matches for Onco-Carbide



Hydroxycarbamide

Hydroxycarbamide is reported as an ingredient of Onco-Carbide in the following countries:


  • Italy

International Drug Name Search

Thursday 15 January 2009

Maximum Strength Aspro Clear




Maximum Strength Aspro Clear may be available in the countries listed below.


Ingredient matches for Maximum Strength Aspro Clear



Aspirin

Acetylsalicylic Acid is reported as an ingredient of Maximum Strength Aspro Clear in the following countries:


  • Malta

International Drug Name Search

Dacatic




Dacatic may be available in the countries listed below.


Ingredient matches for Dacatic



Dacarbazine

Dacarbazine is reported as an ingredient of Dacatic in the following countries:


  • Finland

International Drug Name Search

Wednesday 14 January 2009

Zemuron


Zemuron is a brand name of rocuronium, approved by the FDA in the following formulation(s):


ZEMURON (rocuronium bromide - injectable; injection)



  • Manufacturer: SCHERING

    Approval date: March 17, 1994

    Strength(s): 100MG/10ML (10MG/ML) [RLD][AP], 50MG/5ML (10MG/ML) [RLD][AP]

Has a generic version of Zemuron been approved?


A generic version of Zemuron has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Zemuron and have been approved by the FDA:


rocuronium bromide injectable; injection



  • Manufacturer: APP PHARMS

    Approval date: December 29, 2008

    Strength(s): 100MG/10ML (10MG/ML) [AP], 50MG/5ML (10MG/ML) [AP]


  • Manufacturer: BIONICHE PHARMA USA

    Approval date: November 26, 2008

    Strength(s): 100MG/10ML (10MG/ML) [AP], 50MG/5ML (10MG/ML) [AP]


  • Manufacturer: HOSPIRA

    Approval date: November 26, 2008

    Strength(s): 100MG/10ML (10MG/ML) [AP], 50MG/5ML (10MG/ML) [AP]


  • Manufacturer: SAGENT STRIDES

    Approval date: July 28, 2010

    Strength(s): 100MG/10ML (10MG/ML) [AP], 50MG/5ML (10MG/ML) [AP]


  • Manufacturer: SANDOZ

    Approval date: December 5, 2008

    Strength(s): 100MG/10ML (10MG/ML) [AP], 50MG/5ML (10MG/ML) [AP]


  • Manufacturer: TEVA PARENTERAL

    Approval date: November 26, 2008

    Strength(s): 100MG/10ML (10MG/ML) [AP], 50MG/5ML (10MG/ML) [AP]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Zemuron. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Zemuron.

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • August 28, 2011 - NEW PATIENT POPULATION

    • February 28, 2012 - PEDIATRIC EXCLUSIVITY

See also...

  • Zemuron Consumer Information (Wolters Kluwer)
  • Zemuron Consumer Information (Cerner Multum)
  • Zemuron AHFS DI Monographs (ASHP)
  • Rocuronium Consumer Information (Wolters Kluwer)
  • Rocuronium Consumer Information (Cerner Multum)
  • Rocuronium Bromide AHFS DI Monographs (ASHP)

Sunday 11 January 2009

Prepodyne




Prepodyne may be available in the countries listed below.


Ingredient matches for Prepodyne



Iodine

Iodine is reported as an ingredient of Prepodyne in the following countries:


  • Japan

International Drug Name Search

Byetta



Pronunciation: ex-EN-a-tide
Generic Name: Exenatide
Brand Name: Byetta


Byetta is used for:

Treating type 2 diabetes.


Byetta is a glucagon-like peptide-1 (GLP-1) receptor agonist. It lowers blood sugar by increasing the release of insulin from the pancreas. It also mimics the actions of certain hormones that lower blood sugar levels.


Do NOT use Byetta if:


  • you are allergic to any ingredient in Byetta

  • you have type 1 diabetes

  • you have a buildup of ketones in the blood or urine caused by diabetes (diabetic ketoacidosis)

  • you have severe kidney problems or severe stomach or bowel problems

Contact your doctor or health care provider right away if any of these apply to you.



Before using Byetta:


Some medical conditions may interact with Byetta. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have a history of stomach or bowel problems, gallbladder problems (eg, gallstones), inflammation of the pancreas (pancreatitis), high blood triglyceride levels, alcohol abuse, kidney problems or kidney transplant, or if you receive dialysis

  • if you are also using insulin

  • if you are taking lovastatin

Some MEDICINES MAY INTERACT with Byetta. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Insulin, meglitinides (eg, repaglinide), sulfonylureas (eg, glipizide), or thiazolidinediones (eg, pioglitazone) because the risk of low blood sugar may be increased

  • Angiotensin-converting enzyme (ACE) inhibitors (eg, lisinopril), diuretics (eg, furosemide, hydrochlorothiazide), nonsteroidal anti-inflammatory drugs (NSAIDs) (eg, ibuprofen), or other medicines that may affect kidney function (eg, aminoglycoside antibiotics, such as gentamicin; amphotericin B; cyclosporine; tacrolimus; vancomycin) because the risk of kidney problems may be increased. Ask your doctor if you are unsure if any of your medicines might affect kidney function

  • Anticoagulants (eg, warfarin) because the risk of their side effects may be increased by Byetta

Ask your health care provider if Byetta may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Byetta:


Use Byetta as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Byetta comes with an extra patient information sheet called a Medication Guide and a user manual for the pen. Read them carefully. Read them again each time you get Byetta refilled.

  • Use Byetta within 1 hour before your morning and evening meals (or before the 2 main meals of the day), unless your doctor tells you otherwise. Do NOT use it after a meal. Your doses of Byetta should be about 6 hours or more apart.

  • If you will be using Byetta at home, a health care provider will teach you how to use it. Be sure you understand how to use Byetta. Follow the procedures you are taught when you use a dose. Contact your health care provider if you have any questions.

  • Do not mix Byetta with insulin. Do not transfer Byetta from the pen into a syringe or vial.

  • Inject Byetta into your upper leg (thigh), stomach area (abdomen), or upper arm as directed by your doctor or other health care provider.

  • Use the proper technique taught to you by your doctor. Inject deep under the skin, NOT into a vein or muscle.

  • Do not use Byetta if it contains particles, is cloudy or discolored, or if the vial is cracked or damaged.

  • If you are taking certain medicines by mouth (eg, antibiotics, birth control pills), you may need to take them at least 1 hour before you use Byetta. Ask your doctor, pharmacist, or other health care provider if you need to take any of your medicines at a different time than Byetta.

  • Keep this product, as well as syringes and needles, out of the reach of children and pets. Do not reuse needles, syringes, or other materials. Ask your health care provider how to dispose of these materials after use. Follow all local rules for disposal.

  • If you miss a dose of Byetta, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.

Ask your health care provider any questions you may have about how to use Byetta.



Important safety information:


  • Byetta may cause dizziness. This effect may be worse if you take it with alcohol or certain medicines. Use Byetta with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Do NOT use more than the recommended dose without checking with your doctor.

  • Carry an ID card at all times that says you have diabetes. Check your blood sugar levels as directed by your doctor. If they are often higher than they should be and you take Byetta exactly as prescribed, tell your doctor.

  • Follow the diet and exercise program given to you by your health care provider. Proper diet, regular exercise, and regular testing of blood sugar are important for best results when using Byetta.

  • The risk of low blood sugar may be increased when Byetta is used with certain other diabetes medicines (eg, insulin, meglitinides, sulfonylureas, thiazolidinediones). Low blood sugar may make you anxious, sweaty, weak, dizzy, drowsy, or faint. It may also make your heart beat faster; make your vision change; give you a headache, chills, or tremors; or make you hungrier. It is a good idea to carry a reliable source of glucose (eg, tablets, gel) to treat low blood sugar. If this is not available, you should eat or drink a quick source of sugar like table sugar, honey, candy, orange juice, or non-diet soda. This will raise your blood sugar level quickly. Tell your doctor right away if this happens. To prevent low blood sugar, eat meals at the same time each day and do not skip meals.

  • Byetta may decrease your appetite, the amount of food you eat, and your weight. This is normal. Do not change your dose of Byetta without checking with your doctor.

  • Patients taking Byetta have developed a severe and sometimes fatal pancreas problem (pancreatitis). Contact your doctor right away if you develop severe or persistent stomach pain that may radiate to the back (with or without nausea or vomiting).

  • If vomiting or diarrhea occurs, you will need to take care not to become dehydrated. Contact your doctor for instructions.

  • Do not store the pen with the needle attached. If the needle is left on, the medicine may leak from the pen or air bubbles may form in the cartridge.

  • Lab tests, including hemoglobin A1c levels, blood sugar levels, and kidney function, may be performed while you use Byetta. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.

  • Byetta should be used with extreme caution in CHILDREN; safety and effectiveness in children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Byetta while you are pregnant. It is not known if Byetta is found in breast milk. If you are or will be breast-feeding while you use Byetta, check with your doctor. Discuss any possible risks to your baby.


Possible side effects of Byetta:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Constipation; decreased appetite; diarrhea; dizziness; feeling jittery; headache; indigestion; nausea; vomiting; weakness; weight loss.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing or swallowing; tightness in the chest; swelling of the mouth, face, lips, throat, or tongue; unusual hoarseness); chest pain; fainting; fast heartbeat; severe dizziness; severe or persistent headache, diarrhea, nausea, or vomiting; severe or persistent stomach pain that may radiate to the back (with or without nausea or vomiting); symptoms of kidney problems (eg, change in the amount of urine produced, unusual or persistent pain in the mid to lower back, unexplained swelling); symptoms of low blood sugar (eg, chills, confusion, drowsiness, increased hunger, increased sweating, irritability, nervousness, tremor, blurred vision, weakness).



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Byetta side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include dizziness; severe nausea or vomiting; symptoms of low blood sugar (eg, chills, confusion, drowsiness, fainting, fast heartbeat, increased hunger, increased sweating, irritability, nervousness, severe dizziness, tremor, blurred vision, weakness).


Proper storage of Byetta:

Store unused (unopened) pens in the refrigerator, between 36 and 46 degrees F (2 and 8 degrees C). Do not freeze. Do not use Byetta if it has been frozen. Store used (open) pens below 77 degrees F (25 degrees C). Protect from light. Do not store with the needle attached to the pen. Throw away a used pen 30 days after first use, even if some medicine remains in the pen. Do not use past the expiration date. Keep Byetta out of the reach of children and away from pets.


General information:


  • If you have any questions about Byetta, please talk with your doctor, pharmacist, or other health care provider.

  • Byetta is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Byetta. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Byetta resources


  • Byetta Side Effects (in more detail)
  • Byetta Use in Pregnancy & Breastfeeding
  • Byetta Drug Interactions
  • Byetta Support Group
  • 50 Reviews for Byetta - Add your own review/rating


Compare Byetta with other medications


  • Diabetes, Type 2

Thursday 8 January 2009

Tiadyl




Tiadyl may be available in the countries listed below.


Ingredient matches for Tiadyl



Candesartan

Candesartan cilexetil (a derivative of Candesartan) is reported as an ingredient of Tiadyl in the following countries:


  • Argentina

International Drug Name Search

Tuesday 6 January 2009

Noostan




Noostan may be available in the countries listed below.


Ingredient matches for Noostan



Piracetam

Piracetam is reported as an ingredient of Noostan in the following countries:


  • Argentina

  • Portugal

International Drug Name Search

Karin




Karin may be available in the countries listed below.


Ingredient matches for Karin



Clarithromycin

Clarithromycin is reported as an ingredient of Karin in the following countries:


  • Israel

International Drug Name Search

Monday 5 January 2009

Omeprazol Egis




Omeprazol Egis may be available in the countries listed below.


Ingredient matches for Omeprazol Egis



Omeprazole

Omeprazole is reported as an ingredient of Omeprazol Egis in the following countries:


  • Poland

International Drug Name Search

Sunday 4 January 2009

Dactinomycine




Dactinomycine may be available in the countries listed below.


Ingredient matches for Dactinomycine



Dactinomycin

Dactinomycine (DCF) is known as Dactinomycin in the US.

International Drug Name Search

Glossary

DCFDénomination Commune Française

Click for further information on drug naming conventions and International Nonproprietary Names.

Angoron




Angoron may be available in the countries listed below.


Ingredient matches for Angoron



Amiodarone

Amiodarone hydrochloride (a derivative of Amiodarone) is reported as an ingredient of Angoron in the following countries:


  • Greece

International Drug Name Search